5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry — Marco Proietti (2017) | RDL Network
5769Changes in thromboembolic risk profile and antithrombotic therapy use over a decade: a comparison of Euro Heart Survey on AF and EURObservational research programme AF pilot registry
Article 2017 en
Authors
MP
Marco Proietti
PB
Pierre Bouvet
CL
C Laroche
Abstract
2 min read
Background:In experimental studies gut microbiota-dependent metabolites, in particular trimethylamine N-oxide (TMAO), have recently been reported to promote atherosclerosis and thrombosis.Here, we examined for the first time the relation of the gut microbe-dependent metabolite TMAO with the severity of aortic atherosclerosis.Moreover, the relation between choline and TMAO and the risk of cardiovascular events and recurrent stoke was determined in a derivation and a validation cohort of patients with first-ever ischemic stroke.Method: In a derivation study, the relationship of plasma TMAO levels with the severity of aortic atherosclerosis as assessed by transesophageal echocardiography was characterized in patients admitted with ischemic stroke (n=79).The relation between TMAO and choline with subsequent (1-year) cardiovascular events including myocardial infarction, recurrent stroke and death was examined in the derivation, and in a second independent validation cohort (n=593).Results: A close correlation was observed between TMAO levels and the severity of aortic atherosclerosis (r=0.39,P<0.01).In the initial study higher TMAO plasma levels were linked with an increased incident risk of cardiovascular events over a 1-year follow-up (HR: 2.31; 95% CI: 1.25-4.23;P<0.01).In the validation cohort, a markedly increased risk of cardiovascular events over a 1-year follow-up was observed in patients with high TMAO ((Quartile (Q) 4 vs Q1; HR: 5.0, 95% CI: 1.7 -14.8;P<0.01), but not choline levels.This was also observed after adjustment for sex, age, stroke severity, stroke etiology and cardiovascular risk factors including hypertension, diabetes and history of peripheral or coronary artery disease or myocardial infarction (Q4 vs Q1: HR 3.5; 95% CI: 1.1.-11.2;P=0.03).Moreover, patients with high TMAO levels were at greater risk of recurrent stroke (Q4 vs Q4: HR 2.7; 95% CI: 1.1.-6.1;P<0.01).Conclusion: These results suggest a close relation between the gut microbiotadependent metabolite TMAO and severity of aortic atherosclerosis in humans.The findings demonstrate for the first time a graded relation between TMAO levels and the risk of subsequent combined cardiovascular events and also recurrent stroke alone in patients with recent prior ischemic stroke.
Marta Guasch‐Ferré, Frank B Hu, Miguel Ruiz‐Canela, Mònica Bulló, Edward Yu, Yan Zheng, Estefanía Toledo, Dong D. Wang, Adela Hruby, Dolores Corella, Enrique Gómez‐Gracia, Miquel Fiol, Ramón Estruch, José Lapetra, Montserrat Fitó, Fernando Arós, Lluís Serra‐Majem, Emilio Ros, Liming Liang, Clary B. Clish, Miguel Ángel Martínez‐González, Jordi Salas‐Salvadó
Sylvia E. Choi, Tommaso Bucci, Jiayi Huang, Kai‐Hang Yiu, Christopher Tze‐Wei Tsang, Kui Kai Lau, Andrew Hill, Greg Irving, Professor Gregory Lip, Azmil H. Abdul‐Rahim
Radosław Lenarczyk, Katarzyna Mitręga, Michał Mazurek, Marianna Janion, Grzegorz Opolski, Jarosław Dróżdż, Witold Streb, Artur Fuglewicz, Adam Sokal, Cécile Laroche, Professor Gregory Lip, Zbigniew Kalarus
Christopher Papandreou, Mònica Bulló, Pablo Hernández‐Alonso, Miguel Ruiz‐Canela, Jun Li, Marta Guasch‐Ferré, Estefanía Toledo, Clary B. Clish, Dolores Corella, Ramón Estruch, Emilio Ros, Montserrat Fitó, Ángel M. Alonso‐Gómez, Miquel Fiol, José Manuel Santos‐Lozano, Lluís Serra‐Majem, Liming Liang, Miguel Ángel Martínez‐González, Frank B Hu, Jordi Salas‐Salvadó
Professor Gregory Lip, Cécile Laroche, Mircea Ioachim Popescu, Lars Hvilsted Rasmussen, Laura Vitali Serdoz, Gheorghe‐Andrei Dan, Zbigniew Kalarus, Harry J.G.M. Crijns, Mário Oliveira, Luigi Tavazzi, Aldo Maggioni, Giuseppe Boriani
Discussion(0)
No comments yet. Be the first to comment.